GlassScriptPhysician profile
Ijaz Ahmad
NPI 1902895238
$16,157.94
in general payments reported to CMS, 2019-2025
48 companies · $1,974 in 2025
The $1,974 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,452 · 2020: $1,729 · 2021: $2,312 · 2022: $1,683 · 2023: $2,589 · 2024: $3,419 · 2025: $1,974.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,880 · Education: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,879.53 |
| Education | $102.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,054.70 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,408.97 | 2019-2025 | Jardiance |
| Abbott Laboratories | $1,391.34 | 2019-2024 | Aveir, Diamondback Peripheral, Pressurewire |
| Novartis Pharmaceuticals Corporation | $1,160.05 | 2019-2025 | |
| Amgen INC. | $1,106.14 | 2019-2024 | Repatha |
| Merck Sharp & Dohme LLC | $1,028.77 | 2019-2025 | Verquvo, Capvaxive |
| Pfizer INC. | $946.96 | 2019-2025 | |
| Glaxosmithkline, LLC. | $562.31 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $519.01 | 2019-2024 | Mounjaro, Zepbound |
| Amarin Pharma, INC. | $446.68 | 2019-2021 | |
| Azurity Pharmaceuticals, INC. | $414.77 | 2024-2025 | Edarbi |
| E.R. Squibb & Sons, L.L.C. | $363.30 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $331.06 | 2019-2024 | Xarelto |
| Kerecis Limited | $305.37 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Sanofi-Aventis U.S. LLC | $275.80 | 2019-2022 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $255.77 | 2024-2025 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $220.54 | 2019 | |
| Medtronic, INC. | $195.60 | 2021-2022 | |
| Esperion Therapeutics, INC. | $190.75 | 2021-2025 | Nexletol |
| Next Science LLC | $182.02 | 2023-2025 | Xperience, Blastx, Surgx |
| Horizon Therapeutics Plc | $170.62 | 2019-2022 | |
| Novo Nordisk INC | $170.02 | 2019-2025 | Rybelsus, Ozempic |
| Acumed LLC | $161.48 | 2023 | Acumed, Osteomed |
| Inari Medical, INC. | $155.06 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Alnylam Pharmaceuticals INC. | $145.43 | 2019-2023 | Amvuttra |
| Arbor Pharmaceuticals, INC. | $112.36 | 2019-2021 | |
| Scpharmaceuticals INC. | $111.89 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.60 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $84.93 | 2023-2024 | Inpefa |
| Kowa Pharmaceuticals America, INC. | $62.87 | 2019-2021 | |
| Exact Sciences Corporation | $54.92 | 2025 | The Cologuard Plus Collection Kit |
| Access Pro Medical, LLC | $49.83 | 2023 | Matriderm |
| Infobionic, INC | $43.80 | 2019-2020 | |
| Mannkind Corporation | $38.61 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $36.20 | 2022 | |
| Biotronik INC. | $32.24 | 2023 | Biomonitor |
| Terumo Medical Corporation | $28.90 | 2019-2021 | |
| Kci USA, INC. | $26.29 | 2021 | |
| Djo, LLC | $24.25 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $22.50 | 2023 | Arcalyst |
| Vivaquant INC, Dba Rhythm Express | $22.07 | 2025 | Rhythm Express |
| Philips North America LLC | $22.06 | 2025 | Mcot |
| Vifor Pharma, INC. | $21.52 | 2019 | |
| Smith+Nephew, INC. | $19.75 | 2020 | |
| Abbvie INC. | $18.92 | 2024 | |
| Genentech USA, INC. | $18.52 | 2019 | |
| Medtronic Vascular, INC. | $17.13 | 2020 | |
| Boston Scientific Corporation | $16.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ijaz Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.